References
- Grussendorf-Conen EI, Jacobs S. Efficacy of imiquimod 5% cream in the treatment of recalcitrant warts in children. Pediatr Dermatol. 2002;19:263–266.
- Hoyme UB, Hagedorn M, Schindler AE, Schneede P, Hopfenmüller W, Schorn K, Eul A. Effect of adjuvant imiquimod 5% cream on sustained clearance of anogenital warts following laser treatment. Infect Dis Obstet Gynecol. 2002; 10:79–88.
- Bellew SG, Quartarolo N, Janniger CK. Childhood warts: an update. Cutis. 2004;73:379–384.
- Clifton MM, Johnson SM, Roberson PK, Kincannon J, Horn TD. Immunotherapy for recalcitrant warts in children using intralesional mumps or Candida antigens. Pediatr Dermatol. 2003;20:268–271.
- Aynaud O, Buffet M, Roman P, Plantier F, Dupin N. Study of persistence and recurrence rates in 106 patients with condyloma and intraepithelial neoplasia after CO2 laser treatment. Eur J Dermatol. 2008;18:153–158.
- Savoca S, Nardo LG, Rosano TF, D’Agosta S, Nardo F. CO(2) laser vaporization as primary therapy for human papillomavirus lesions. A prospective observational study. Acta Obstet Gynecol Scand. 2001;12:1121–1124.
- Beutner KR, Wiley DJ. Recurrent external genital warts: A literature review. Papillomavirus Rep. 1997;8:69–74.
- Jacobs S, Grussendorf-Conen EI, Rösener S.Molecular analysis of the effect of topical imiquimod treatment of HPV 2/27/57-induced common warts. Skin Pharmacol Physiol. 2004;17:258–266.